IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oric Pharmaceuticals, Inc.

CUSIP: 06822P109 | 1 institutional holders

Quarters

Q4 2020Q3 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2020

Foresite Capital Management III, LLC496,893
0.2% of portfolio›$16.8K
StyleTurnoverLocationFiled
Foresite Capital Management III, LLC
496,893$16.8K0.2%N/AN/ASan Francisco, CA2021-02-16